Ultra-high B-value diffusion weighted magnetic resonance imaging; the added value at 1.5T

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20140

Enrollment

Registered

2015-11-16

Start date

2015-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Benign prostate hyperplasia

Interventions

none

Eligibility

Inclusion criteria

Inclusion criteria: patients with increased PSA serum values, patients with known and proven prostate cancer, patients with benign prostate hyperplasia

Exclusion criteria

Exclusion criteria: patients with contradictory medical, images with movement artifacts

Design outcomes

Primary

Measure	Time frame
Added diagnostical value to low b-value scans, indicated by radiologists.	—

Secondary

Measure	Time frame
Sufficiant image quality on 1,5T system to be considered for practical application	—

Contacts

Public ContactJordie Dirks

j.dirks@atriummc.nl0031623837405

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)